About Harman Finochem
Harman Finochem is a Healthcare company based in Mumbai (India) founded in 1983. It operates as a manufacturing and exporting of active pharmaceutical ingredients in India. The company has 1,772 employees. Its Indian entity Harman Finochem Limited reported revenue of ₹1,376 Cr. Harman Finochem offers products and services including Metformin and Fenofibrate. Its focus areas include Research and Development, Drug Development, Innovation Services and Pharmaceuticals.
Company details
Harman Finochem Limited is recognized as a key player in the pharmaceutical industry, with active pharmaceutical ingredients being manufactured and exported globally since its establishment in 1983. Core competencies include the production of substances like Metformin and Fenofibrate, supported by world-class facilities and research efforts. Sustainability practices are emphasized, as water recycling and waste reduction initiatives are implemented to achieve targets by 2025 and 2030. Operations are conducted with a focus on quality and environmental responsibility, serving clients worldwide.
- Headquarters Mumbai, India
- Employees 1,772
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Social LinkedIn X Facebook
- Legal Name Harman Finochem Limited
- Date of Incorporation 17 Mar, 1983
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹1,376 Cr
FY 2025 · +27% YoY
- Net Profit₹207 Cr
FY 2025 · 15% margin
- EBITDA₹400 Cr
FY 2025 · 29% margin
- Employee Count1,772
Associated legal entities of Harman Finochem
Harman Finochem operates through Harman Finochem Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Harman Finochem Limited CIN U24110MH1983PLC029560 | Active | 17 Mar 1983 | Mumbai, Maharashtra | ₹1,376 Cr | 1,772 | 5 | View details |
Products & Services of Harman Finochem
Harman Finochem offers a comprehensive portfolio of products and services, including Metformin and Fenofibrate.
Metformin is manufactured and exported as a key active pharmaceutical ingredient for various formulations.
Fenofibrate is produced and supplied as an active ingredient in pharmaceutical applications.
Board of directors of Harman Finochem Limited (Harman Finochem)
Harman Finochem Limited is the primary company behind Harman Finochem. The board of Harman Finochem Limited currently have 5 directors; the longest-serving is Inderjeet Kaur Bhupinder Singh, appointed in 1997. 6 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Inderjeet Kaur Bhupinder Singh DIN 00121284 | Whole-time director | 11 Feb 1997 | 29 yrs 8 mo | Harman Finochem Limited |
| Harpreet Singh Bhupinder Singh DIN 00121336 | Whole-time director | 11 Feb 1997 | 29 yrs 8 mo | Harman Finochem Limited |
| Savreen Minhas DIN 06838530 | Whole-time director | 10 Mar 2014 | 12 yrs 7 mo | Harman Finochem Limited |
| Gurpreet Singh Minhas DIN 01885368 | Whole-time director | 10 Mar 2014 | 12 yrs 7 mo | Harman Finochem Limited |
| Manprrit Minhas DIN 11114724 | Whole-time director | 21 May 2025 | 1 yr 4 mo | Harman Finochem Limited |
People of Harman Finochem
37 people are tracked at Harman Finochem (10 in leadership, 27 in team); the tracked headcount is 1,772.
| Name | Role | Group |
|---|---|---|
Surinder Raina | CEO (Formulations) | Leadership |
Nandkishor Karwande | Head Engineering And Projects | Leadership |
Vilas Sardeshpande | Asst. General Manager - H R | Leadership |
Deepak Nikam | Vice President - Analytical Development (osd, Api) & Quality Control (osd) | Leadership |
Rahul Kulkarni | Deputy General Manager | Leadership |
Deelip Sawant | Vice President Manufacturing Operations | Leadership |
Hiren Soni | Site Head | Leadership |
Rahul Gholap | Warehouse Head | Leadership |
Venkataramana Maneti | General Manager Purchase | Leadership |
K.p Reddy | Project Head | Leadership |
Neeti Mahajan | Corporate HR | Team |
Waman Kulkarni | Sr.executive | Team |
Rahul Dhawale | Executive Mechanical Engineer | Team |
Gagandeep Singh Siledar | Instrumentation Engineer | Team |
Pritesh Sharma | Dy. Manager Engineering | Team |
Siddhartha Kusare | AGM Project | Team |
Vishal Sutar | Sr. Manager Engineering And Project | Team |
Eknath Shelke | Project Manager | Team |
Hemant Patil | Sr.hr Executive | Team |
Gurpreet Singh Kamthekar | Senior Maintenance Engineer | Team |
17 more people are available in the full profile.
Complete people profiles for Harman Finochem
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Harman Finochem
Figures of Harman Finochem Limited, the primary company behind Harman Finochem, for FY 2025. Revenue was ₹1,376 Cr (+27% year on year). Net profit was ₹207 Cr (15% margin). EBITDA was ₹400 Cr (29% margin). Revenue has grown at a compounded annual rate of +19% over three years and +16% over five years.
- ₹1,376 CrRevenue · FY 2025 · +27% YoY
- ₹207 CrNet profit · 15% margin
- ₹400 CrEBITDA · 29% margin
- ₹4.76 CrPaid-up capital
- 1,772Employees (provident fund records)
- +19%Revenue CAGR, 3 years
- +16%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Harman Finochem Limited are on its company page.
Detailed financial statements for Harman Finochem
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of Harman Finochem
The website of Harman Finochem (harmanfinochem.com) receives about 1.4K visits a month and ranks #9,678,229 among all websites worldwide, #7,756 in Biotechnology and Pharmaceuticals.
- Monthly visits1.4K
▼ 6.2% vs previous month
- Global rank#9,678,229
among all websites
- Category rank#7,756
Health · Biotechnology and Pharmaceuticals
- Bounce rate52%
- Pages per visit2.0
- Average visit1 min 03 sec
- DevicesDesktop 58% · Mobile 42%
Websites whose visitors overlap most with Harman Finochem. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| megafine.in | 100% | – | – | View details | |
| edqm.eu | 94% | – | #199,638 | View details | |
| lupin.com | 93% | 216.4K | #208,025 | View details | |
| pharmacompass.com | 93% | 301.1K | #186,920 | View details | |
| aurenalabs.com | 68% | – | #6,146,973 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 10 similar websites and full traffic analytics for Harman Finochem
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 10 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Clinical Trials & Research Tech
10 companies that operate in the same segment as Harman Finochem (Clinical Trials & Research Tech), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Genetic services are provided by Colossal's laboratory operations. | 2021 | Austin, Texas, United States | USD 617.6 M | – | – | |
Research lab engaged in pharmacological measurements on therapeutic protein variants | 2018 | United States | USD 78.19 M | – | 22 | |
Drug development services encompassing clinical trials, bioanalytical support, and real-world evidence in healthcare. | 2004 | Ahmedabad, Gujarat, India | – | USD 50.52 M | 902 | |
Generic injectables for oncology and anesthesiology are manufactured. | 1989 | Hyderabad, Telangana, India | – | USD 4.22 M | 228 | |
Medical research labs are provided by GALY for scientific purposes. | 2018 | Boston, Massachusetts, United States | USD 61.59 M | – | 25 | |
Laboratory focused on biotechnology & molecule research services | 2018 | Cambridge, Massachusetts, United States | USD 32.68 M | – | – | |
Laboratory delivers discovery & research in nuclear and particle physics | 1947 | United States | – | – | 2,436 | |
Research and manufacturing of hemp products are conducted by BRC. | 2017 | Monterey, California, United States | USD 25.26 M | – | 16 | |
Genome sequencing studies are conducted for medical research purposes. | 2020 | Cambridge, Cambridgeshire, United Kingdom | USD 11.26 M | – | 12 | |
Novel immunotherapy therapeutic targets are discovered through laboratory research. | 2019 | Branford, Connecticut, United States | USD 92 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Harman Finochem
Harman Finochem was founded in 1983.
Harman Finochem is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Harman Finochem has 1,772 employees.
The primary company behind Harman Finochem, Harman Finochem Limited, reported revenue of ₹1,376 Cr for FY 2025, up 27% year on year.
Harman Finochem Limited is recognized as a key player in the pharmaceutical industry, with active pharmaceutical ingredients being manufactured and exported globally since its establishment in 1983. Core competencies include the production of substances like Metformin and Fenofibrate, supported by world-class facilities and research efforts. Sustainability practices are emphasized, as water recycling and waste reduction initiatives are implemented to achieve targets by 2025 and 2030. Operations are conducted with a focus on quality and environmental responsibility, serving clients worldwide.
Harman Finochem offers Metformin and Fenofibrate.
Harman Finochem operates through Harman Finochem Limited.
The legal entities of Harman Finochem currently have 5 directors, including Savreen Minhas, Inderjeet Kaur Bhupinder Singh, Gurpreet Singh Minhas and others.